Initiation Archives - Page 9 of 272

2 minute read

This Analyst Is Bullish On Biohaven’s Approach in Neuro-Psych Space

February 16, 2:58 PM

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.

BHVN

2 minute read

Monte Rosa Therapeutics’ AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst

By Vandana Singh

February 15, 3:05 PM

Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the company shows strong potential for value creation.

GLUE

1 minute read

Why This Super Micro Computer Analyst Is Bullish: ‘Revenues Could Grow Even Faster’

By Priya Nigam

February 15, 1:46 PM

Super Micro Computer Inc (NASDAQ: SMCI) has been among the main beneficiaries of the artificial intelligence (AI) market explosion.

SMCI

2 minute read

RBC Illuminates Solar Sector, Launches Coverage For 4 Solar Equipment Leaders

By Erica Kollmann

February 14, 7:41 PM

RBC Capital Markets highlighted favorable public policy and declining costs within the solar industry and initiated coverage on several solar equipment suppliers, including First Solar, Enphase Energy, SolarEdge and Shoals Technologies on Tuesday.

ENPH

1 minute read

Steven Madden To Gain From Brand Value Despite Shifting Trends – Analyst Highlights Almost Famous Acquisition

By Nabaparna Bhattacharya

February 14, 3:18 PM

Analyst sees Steven Madden (NASDAQ: SHOO) benefiting from brand value, Almost Famous acquisition, anticipates low-teens earnings growth in 2024.

SHOO

3 minute read

Disney Analysts Bullish After Q1 Earnings: ‘The Magic’s Back’

By Chris Katje

February 8, 12:40 PM

Analysts are upgrading their price targets on Disney stock after the media company reported first-quarter financial results and shared several announcements.

DIS

2 minute read

UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst

By Vandana Singh

February 6, 3:19 PM

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

ABBV

2 minute read

Broadcom’s Tech Dominance Affirmed by JPMorgan Analyst; Forecasts Company Will Lead AI and Cloud Revolution

By Anusuya Lahiri

February 6, 3:11 PM

JPMorgan analyst initiates coverage of Broadcom with Overweight rating and $1,550 price target. Broad strengths in semiconductors and software.

AVGO

2 minute read

Golden Nuggets: Vision, Market And Sales Figures Of California’s Major Weed Stocks In A Regulatory Storm

By Nicolas Jose Rodriguez

February 6, 12:26 AM

Six years after legalization, California's vast cannabis market faces mixed results. While generating over $5.7 billion in taxes, it falls short of financial expectations due to oversupply, illicit trade and local bans.

GRAM

1 minute read

Applied Optoelectronics Set For Explosive Growth In AI Optical Tech By 2025, Says Bullish Analyst

By Priya Nigam

January 30, 11:13 AM

Shares of Applied Optoelectronics Inc (NASDAQ: AAOI) were recovering on Tuesday, after last week’s steep decline.

AAOI